Malacañang on Tuesday distanced itself from the alleged six pro-government party-list organizations vying in the May elections, insisting it has not endorsed any group supposedly to augment the administration’s representation in Congress.

Deputy Presidential Spokesman Gary Olivar even encouraged the Comelec to scrutinize further the six party-list groups suspected as government fronts.

“To my knowledge, the accusations are fraudulent or non-accredited party-list groups. To my knowledge, this is not something that is being done,” Olivar told reporters in the Palace when asked if the government has fielded any party list groups in the elections.

“If there are such allegations, it is up to the Comelec to judge and issue a decision on the matter,” he added.

Olivar said the Comelec has the oversight of the electoral process, including the accreditation of party list organizations, and the Palace has nothing to do with it.  “We will leave to the discretion and the authority of Comelec,” he added.

Olivar likewise groups criticizing the alleged administration-backed party-list groups to stop blaming the President and instead bring their complaints to the Comelec. “They should talk to the Comelec and not Malacañang about this matter. The Palace is not involved in this,” he said.

An election watchdog, Kontra Daya, earlier questioned the accreditation of six party-list groups which were allegedly backed by the Arroyo administration.

Under suspicion are Batang Iwas Droga (Bida), Adhikain ng mga Dakilang Anak ng Maharlika (Adam), Agbiag Timpuyog Ilokano (Agbiag), Babae para sa Kaunlaran (Babae Ka), League of Youth for Peace and Development (Lypad), and Kalahi Advocates for Overseas Filipinos (Kalahi).

Kontra Daya said the inclusion of these six party-list groups violates the law that established the party-list system that provides congressional representation for marginalized and underrepresented sectors of society.

Poll officials however claimed the suspected pro-government party-list groups have passed its thorough screening.